If you had lung cancer, you’d take one kind of drug. If you had liver cancer, you’d take another drug. Makes sense, right? But scientists have found another, more effective, more targeted way to treat cancer — one that you need a code to unlock. In this episode we look at the surprising history and the hopeful future of immunotherapy, and how the genetic code of cancer itself has been used to find a way to treat the disease.

Featuring:

• Neeha Zaidi is a medical oncologist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre. 
• Mike Yee is Jefferies’ managing director and senior biotech analyst
• Neville Sanjana is a core faculty member at the New York genome center and also an assistant professor of biology at NYU

Healthcare innovations aren’t just about drugs, but how care is delivered. But one of the fastest-growing areas of health care is focusing less on WHAT’s wrong with you, but WHERE the healing actually happens, and HOW doctors can deliver that care right to your home. In this episode we learn how a fitness craze from the 80’s is helping provide medical care right to a patient’s front door.

Featuring:

• Raphael Rakowski is the founder of Medically Home
• Elizabeth Krupinski is a professor at Emory University and the co-author of the book Understanding Telehealth
• Brian Tanquilut is a healthcare services analyst at Jefferies

The discovery of DNA in the 1850s allowed us to see into the genetic code of individual humans. Now gene editing, a technique by which the gene or genes that make us susceptible to some diseases, allows that code to be rewritten. In this episode we look at the ways in which gene editing is being used to turn that century-old breakthrough into the future of medicine.

Featuring:

• Pino Ciaramella is the chief scientific officer and president of Beam Therapeutics 
• Paul Offit is the director of the Vaccine Education Centre at the Children’s Hospital of Philadelphia, and a professor at the University of Pennsylvania. He is the author of the book You Bet Your Life: The Long and Risky History of Medical Innovation  
• Neville Sanjana is a core faculty member at the New York genome center and also an assistant professor of biology at NYU
• Will Sevush is Jefferies’ healthcare desk specialist